[Use of new protocols in the management of nephrotic syndrome in black African children. Experience of the University Hospital Center of Yopougon (Abidjan, Côte-d'Ivoire)].
Adonis-Koffy
L Y
LY
Timité-Konan
A M
AM
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D044383:Black People; D002648:Child; D002985:Clinical Protocols / Q000592:standards*; D007560:Cote d'Ivoire; D003520:Cyclophosphamide / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007978:Levamisole / Q000627:therapeutic use*; D008775:Methylprednisolone / Q000627:therapeutic use*; D009404:Nephrotic Syndrome / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D007978:Levamisole; D003520:Cyclophosphamide; D008775:Methylprednisolone